MOLECULAR MECHANISMS OF ORGANOPHOSPHATE IMMUNOTOXICITY
MOLECULAR MECHANISMS OF ORGANOPHOSPHATE IMMUNOTOXICITY
批准号:
3465157
负责人:
KATHLEEN E. RODGERS
金额:
$7.28万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-09-01 至 1992-11-30
关键词:
autoradiography cell differentiation cell type chemical structure function chemical synthesis colorimetry covalent bond cytotoxicity diagnosis design /evaluation environmental toxicology enzyme inhibitors enzyme mechanism flow cytometry free radicals gel electrophoresis human tissue immunoprecipitation immunosuppression immunotoxicity insecticide biological effect laboratory mouse leukocyte activation /transformation macrophage molecular site organophosphorus insecticide parathion pesticide interaction radiotracer rapid diagnosis scintillation counter superoxides tissue /cell culture toxicant screening
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The molecular mechanisms of immune suppression by two impurities in the
organosphosphate pesticides, malathion, acephate and fenitrothion,
O,O,S-trimethyl phosphorothioate (OOS-TMP) and O,S,S-trimethyl
phosphorodithioate, will be examined. Macrophaages, through cell
separation and reconstitution experiments, have been shown to be the
lymphoid cell most affected by OOS-TMP treatment. The blockage in the
maturation of macrophages which occurs following acute administration of
OOS-TMP will be identified. Studies will include changes in macrophage
cell surface markers, Ia, Mac-1, Mac-2 and F4/80, functional activity and
secretory products. The inhibitory effect of a structural analog OSS-TMP
on cytolytic effector function will be examined in detail using
functionally defined cytotoxic T lymphocytes (CTL) and other cytolytic
effector cells. The site(s) of the blockade of murine CTL function will be
determined using conjugate formation and Ca2+ pulse techniques. The
molecular sites will be identified using radiolabelled OSS-TMP and
biochemical analyses. In addition, an adaptation of a colorimetric assay
(dye reduction) for cell viability will be investigated for its suitability
as a screening assay for the cytotoxic and cytostatic activities of
environmental toxicants. This assay may be an alternative to the standard
trypan blue exclusion method for assessing cell viability.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease.
-
批准号:10530821
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2020
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease.
-
批准号:10396541
-
项目类别:
-
资助金额:$151.56万
-
财政年份:2020
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease.
-
批准号:10644987
-
项目类别:
-
资助金额:$152.86万
-
财政年份:2020
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
A(1-7)-Mediated Mitigation of Radiation Induced Thrombocytopenia
-
批准号:8058309
-
项目类别:
-
资助金额:$43.16万
-
财政年份:2010
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
NorLeu3-A(1-7): Enhanced Recovery of Radiation Burns
-
批准号:8055215
-
项目类别:
-
资助金额:$67.43万
-
财政年份:2010
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin(1-7): A Target in Diabetic Cardiac Ischemia
-
批准号:7609180
-
项目类别:
-
资助金额:$34.15万
-
财政年份:2008
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin(1-7): A Target in Diabetic Cardiac Ischemia
-
批准号:7797462
-
项目类别:
-
资助金额:$34.05万
-
财政年份:2008
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
A(1-7)-Mediated Mitigation of Radiation Induced Thrombocytopenia
-
批准号:7552457
-
项目类别:
-
资助金额:$90.74万
-
财政年份:2008
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin(1-7): A Target in Diabetic Cardiac Ischemia
-
批准号:7462238
-
项目类别:
-
资助金额:$35.72万
-
财政年份:2008
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
NorLeu3-A(1-7): Enhanced Recovery of Radiation Burns
-
批准号:7575590
-
项目类别:
-
资助金额:$94.23万
-
财政年份:2008
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin Analogs to Treat Wound Healing
-
批准号:7414073
-
项目类别:
-
资助金额:$85.92万
-
财政年份:2007
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin Analogs to Treat Wound Healing
-
批准号:8134084
-
项目类别:
-
资助金额:$20.73万
-
财政年份:2007
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin Analogs to Treat Wound Healing
-
批准号:7270998
-
项目类别:
-
资助金额:$92.41万
-
财政年份:2007
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin Analogs to Treat Wound Healing
-
批准号:7624290
-
项目类别:
-
资助金额:$86.08万
-
财政年份:2007
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Project 3: Peripheral Immune Activation on the Road to Development of Alzheimer's Disease: Therapeutic Targets and Windows
-
批准号:10172751
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2006
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Project 3: Peripheral Immune Activation on the Road to Development of Alzheimer's Disease: Therapeutic Targets and Windows
-
批准号:10412244
-
项目类别:
-
资助金额:$37.05万
-
财政年份:2006
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Project 3: Peripheral Immune Activation on the Road to Development of Alzheimer's Disease: Therapeutic Targets and Windows
-
批准号:10659128
-
项目类别:
-
资助金额:$40.61万
-
财政年份:2006
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin Analogs to Treat Wound Healing
-
批准号:6945913
-
项目类别:
-
资助金额:$42.97万
-
财政年份:2004
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin Analogs to Treat Wound Healing
-
批准号:6741664
-
项目类别:
-
资助金额:$96.03万
-
财政年份:2004
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
ANGIOTENSIN ANALOGS TO TREAT WOUND HEALING
-
批准号:6292904
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2001
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
海外基金